List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of protein identified exclusively in cisplatin treated A2780-CisR cells. Table S3. List of protein identified mutually in untreated and cisplatin treated A2780-CisR cells (XLSX 26 kb
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
Table S1. CDDP sensitivity assay of tissue samples from lung cancer patients (please refer to Additi...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
SP differentiation assay for evaluation of CSC enrichment in TOV21G and SKOV3. A & B. Quantification...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
Endogenous abundance of subpopulations from differentiation states and subsequent to short-term cisp...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
Figure S1. PCA clustering of splicing inclusion level differences between treated and untreated PDX ...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
In vivo limiting dilution assays of sorted MDA-MB-231 and MDA-MB-453 breast cancer cells using surfa...
Primer sequences for quantitative real-time-PCR. Sequences of primers (5′-3′) used for quantitative ...
Table S1. Luciferase activity levels of clonally selected ID8 cells stably transfected with PB-CAG-L...
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
Table S1. CDDP sensitivity assay of tissue samples from lung cancer patients (please refer to Additi...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
SP differentiation assay for evaluation of CSC enrichment in TOV21G and SKOV3. A & B. Quantification...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
Endogenous abundance of subpopulations from differentiation states and subsequent to short-term cisp...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
Figure S1. PCA clustering of splicing inclusion level differences between treated and untreated PDX ...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
In vivo limiting dilution assays of sorted MDA-MB-231 and MDA-MB-453 breast cancer cells using surfa...
Primer sequences for quantitative real-time-PCR. Sequences of primers (5′-3′) used for quantitative ...
Table S1. Luciferase activity levels of clonally selected ID8 cells stably transfected with PB-CAG-L...
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
Table S1. CDDP sensitivity assay of tissue samples from lung cancer patients (please refer to Additi...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...